Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Lu AE 04621
/
Lundbeck
Welcome,
Profile
Billing
Logout
0 Diseases
0 Trials
0 Trials
3 News
|
|||||||||
Lu AE 04621
/
Lundbeck
Trial completion, Enrollment change:
An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 in Parkinson Disease Patients
(clinicaltrials.gov) - Dec 19, 2016
P1
, N=15, Completed,
Sponsor: H. Lundbeck A/S
Recruiting --> Completed | N=24 --> 15
||||||||||
Lu AE 04621
/
Lundbeck
Enrollment open:
An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 in Parkinson Disease Patients
(clinicaltrials.gov) - Jan 24, 2016
P1
, N=24, Recruiting,
Sponsor: H. Lundbeck A/S
Recruiting --> Completed | N=24 --> 15 Not yet recruiting --> Recruiting
|
|||||||||
Lu AE 04621
/
Lundbeck
New P1 trial:
An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 in Parkinson Disease Patients
(clinicaltrials.gov) - Jan 7, 2016
P1
, N=24, Not yet recruiting,
Sponsor: H. Lundbeck A/S